Ordinary Share Capital 更改
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
Agios Pharmaceuticals USD 72K 0 2023-12
Amgen USD 32.75B 152M 2023-09
Astellas Pharma JPY 103B 0 2023-09
Bayer EUR 2.52B 0 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Celldex Therapeutics USD 56K 9K 2023-12
Daiichi Sankyo JPY 50B 0 2023-09
Eisai JPY 44.99B 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Esperion Therapeutics USD 112K 11K 2023-09
Exelixis USD 311K 9K 2023-09
Genmab DKK 66M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
GlaxoSmithKline GBP 1.35B 0 2023-09
Incyte USD 224K 0 2023-12
Insmed USD 1.48M 50K 2023-12
Merck USD 1.79B 0 2023-09
Moderna USD 38.2K 100 2023-12
Nektar Therapeutics USD 19K 0 2023-09
Novartis USD 825M 17M 2023-09
Pfizer USD 478M 0 2023-09
Regeneron Pharmaceuticals USD 102K 0 2023-09
Sarepta Therapeutics USD 9K 0 2023-09
Takeda JPY 1.68T 92M 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09
Xencor USD 611K 4K 2023-12



Seattle Genetics 普通股股本 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.